NCT06113835View on ClinicalTrials.gov

Viable Myocardium Detected by Hybrid PET/MR and SPECT for the Prediction of the Efficacy of PCI in Patients With CTO.

RecruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

February 22, 2023

Primary Completion Date

October 30, 2024

Study Completion Date

March 30, 2025

Conditions
Chronic Total Occlusion of Coronary Artery
Interventions
PROCEDURE

CTO PCI

percutaneous coronary intervention

Trial Locations (1)

210029

RECRUITING

First Affiliated Hospital of Nanjing Medical University, Nanjing

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER

NCT06113835 - Viable Myocardium Detected by Hybrid PET/MR and SPECT for the Prediction of the Efficacy of PCI in Patients With CTO. | Biotech Hunter | Biotech Hunter